End-Stage Kidney DiseasePhase 4RESOLVENCT02823821
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
A Phase 4 study testing Default dialysate sodium concentration of 137mmol/l and Default dialysate sodium concentration of 140mmol/l in people with End-Stage Kidney Disease, run by University of Sydney at 264 sites in 6 countries.
Trial summary
This global study will assess the effect of randomising dialysis sites to one of two default dialysate sodium concentrations in current practice, 140mmol/l and 137mmol/l, on major cardiovascular events and death in patients receiving maintenance haemodialysis. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- End-Stage Kidney Disease
- What is being tested?
- Default dialysate sodium concentration of 137mmol/l and Default dialysate sodium concentration of 140mmol/l
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50,000 participants
- Where
- 264 sitesin 6 countries
- Study dates
- Jun 2016to Dec 2026
- Phase
- Phase 4
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
The site inclusion criteria are:
- Predominantly dialyses adults (≥18 years old) receiving maintenance haemodialysis
- Rates of withdrawal within the first two years of commencing dialysis for social reasons have been less than 15% for the 2 years prior to recruitment and are not expected to increase above 15%
- Has a minimum of 10 dialysis recipients at time of randomisation
- Utilises a default dialysate sodium concentration at the time of recruitment (a substantial majority of dialysis sessions are conducted with the default dialysate sodium concentration)
- Is a self-contained unit (i.e. unit patients do not regularly rotate through another unit. Brief trips by patients to a parent or other unit do not exclude a site)
- Willing to accept randomisation to either intervention (as determined by nominated Director of Unit)
- Is not a home dialysis training or support unit. [Sites that include both in-center/satellite dialysis patients and home patients may participate but the study procedures and assessments will only be conducted in the incenter/satellite component of the site].
The exclusion criteria are:
- Not able to comply with data collection methods
Trial locations and contacts
264 sites in 6 countries. Contact the study team or a site near you to ask about taking part.
Grace Balicki contact
Erika Dempsey contact
264 sites in 6 countries
United Kingdom95 sites, 95 recruiting
- Recruiting
Altrincham General Hospital Dialysis Unit
Altrincham
- Recruiting
Tameside Renal Dialysis Unit
Ashton-under-Lyne
- Recruiting
Barnet Satellite Unit
Barnet
- Recruiting
Barnsley Dialysis Unit
Barnsley
- Recruiting
Bath Dialysis Unit
Bath
- Recruiting
Bedford Renal Unit
Bedford
- Recruiting
Bexhill Dialysis Unit
Bexhill-on-Sea
- Recruiting
Hexagon Towers Dialysis Unit
Blackley
- Recruiting
Bolton Kidney Care Centre
Bolton
- Recruiting
St Luke's Hospital Renal Ward
Bradford
- Recruiting
Bridgwater Dialysis Unit
Bridgwater
- Recruiting
Brighton Sussex Kidney Unit
Brighton
- Recruiting
Cossham Dialysis Unit
Bristol
- Recruiting
South Bristol Dialysis Unit
Bristol
- Recruiting
Bromley Dialysis Unit
Bromley
- Recruiting
Broomfield Hospital
Broomfield
- Recruiting
Cannock Haemodialysis Unit
Cannock
- Recruiting
Chesterfield Dialysis Unit
Chesterfield
- Recruiting
Clacton (Diaverum)
Clacton-on-Sea
- Recruiting
Colchester (Diaverum)
Colchester
- Recruiting
Clay Lane
Coventry
- Recruiting
University Hospitals Coventry & Warwickshire Main Unit
Coventry
- Recruiting
Crawley Dialysis Unit
Crawley
- Recruiting
Leighton
Crewe
- Recruiting
Cromer Hospital Dialysis Unit
Cromer
- Recruiting
Darlington Dialysis Unit
Darlington
- Recruiting
Dartford Dialysis Unit
Dartford
- Recruiting
Dover Renal Unit
Dover
- Recruiting
Edgware Satellite Unit
Edgware
- Recruiting
Epsom Dialysis Unit
Epsom
- Recruiting
Heavitree
Exeter
- Recruiting
Farnborough Dialysis Unit
Farnborough
- Recruiting
Cotswold Dialysis Centre
Gloucester
- Recruiting
Severn
Gloucester
- Recruiting
James Paget Renal Unit
Great Yarmouth
- Recruiting
Grimsby Renal Unit
Grimsby
- Recruiting
Harlow Renal Unit
Harlow
- Recruiting
Hayes Hospital
Hayes
- Recruiting
Honiton
Honiton
- Recruiting
Chiltern Renal Unit
Houghton Regis
- Recruiting
Fresenius Hull Dialysis Unit
Hull
- Recruiting
West Middlesex
Isleworth
- Recruiting
Kingston Satellite Dialysis Unit
Kingston
- Recruiting
Collierswood Dialysis Unit
London
- Recruiting
King George Hospital
London
- Recruiting
Mary Rankin Satellite Unit
London
- Recruiting
North Wandsworth Dialysis Unit
London
- Recruiting
Royal London Hospital
London
- Recruiting
Whipps Cross Hospital
London
- Recruiting
Ludlow Dialysis Unit
Ludlow
- Recruiting
Macclesfield District General Hospital
Macclesfield
- Recruiting
Manchester Royal Infirmary Renal Dialysis Unit
Manchester
- Recruiting
Octagon Renal Satellite
Manchester
- Recruiting
Margate Renal Unit
Margate
- Recruiting
James Cook
Middlesbrough
- Recruiting
North Ormesby
Middlesbrough
- Recruiting
Harrogate
North Yorks
- Recruiting
Friarage Hospital
Northallerton
- Recruiting
Lucy Deane (George Eliot)
Nuneaton
- Recruiting
Oldham Dialysis Unit
Oldham
- Recruiting
Newham Hospital
Plaistow
- Recruiting
Eastbourne (Polegate) Dialysis Unit
Polegate
- Recruiting
Rochdale Dialysis Unit
Rochdale
- Recruiting
Queen's Hospital
Romford
- Recruiting
Rotherham Dialysis Unit
Rotherham
- Recruiting
St Cross (Ash Unit)
Rugby
- Recruiting
Salford Renal Unit
Salford
- Recruiting
Scarborough
Scarborough
- Recruiting
Scunthorpe Dialysis Centre
Scunthorpe
- Recruiting
Peter Moorhead Unit
Sheffield
- Recruiting
Renal G Floor
Sheffield
- Recruiting
Sheffield Dialysis Unit
Sheffield
- Recruiting
Shrewsbury Renal Unit
Shrewsbury
- Recruiting
Smethwick Dialysis Centre
Smethwick
- Recruiting
St Albans Dialysis Unit
St Albans
- Recruiting
County Hospital
Stafford
- Recruiting
Lister Renal Unit
Stevenage
- Recruiting
Stockport NHS Dialysis Unit
Stockport
- Recruiting
North Tees
Stockton-on-Tees
- Recruiting
Royal Stoke
Stoke-on-Trent
- Recruiting
Stratford Dialysis Centre
Stratford-upon-Avon
- Recruiting
St. Helier Dialysis Unit
Sutton
- Recruiting
Sutton Dialysis Unit
Sutton
- Recruiting
Taunton Dialysis Centre
Taunton
- Recruiting
Hollinswood House Renal Unit
Telford
- Recruiting
Croydon Dialysis Unit
Thornton Heath
- Recruiting
South Devon Satellite Kidney Unit
Torquay
- Recruiting
Tottenham Hale Satellite Unit
Tottenham
- Recruiting
Wigan Renal Unit
Wigan
- Recruiting
Ashford Renal Unit
Willesborough
- Recruiting
Pond Lane Dialysis Unit
Wolverhampton
- Recruiting
Woolwich Dialysis Unit
Woolwich
- Recruiting
Worthing Dialysis Unit
Worthing
- Recruiting
Easingwold
York
- Recruiting
York Hospital
York
India63 sites, 63 recruiting
- Recruiting
Leelawati Hospital
Ambāla, Haryana
- Recruiting
Jyothi Hospital
Balasore, Odisha
- Recruiting
Koshys Hospital, Ramamurthy Nagar
Bengaluru, Karnataka
- Recruiting
Nephroplus Basaveshwaranagar
Bengaluru, Karnataka
- Recruiting
ESI Hospital
Bhetia, Jharkand
- Recruiting
Kar Clinic & Hospital Pvt. Ltd.
Bhubaneswar, Odisha
- Recruiting
Neelachal Hospital, Kharvel Nagar
Bhubaneswar, Odisha
- Recruiting
K.M Memorial Hospital and Research Centre
Bokāro, Jharkhand
- Recruiting
Nephroplus Borivali Standalone
Borivali West, Mumbai, 400092
Kamal D Shah
Abhinav Bassi
- Recruiting
Bharat Baug
Borivali West, Mumbai
- Recruiting
Deepam Hospitals, Pallavaram
Chennai, Tamil Nadu
- Recruiting
Area Hospital, Kothapeta Road,Chirala, Andhra Pradesh
Chīrāla, Andhra Pradesh
- Recruiting
KG Hospital
Coimbatore, Tamil Nadu
- Recruiting
Asarfi Hospital
Dhanbad, Jharkhand
- Recruiting
Medical Superintendent Government Hospital
Gūdūr, Andhra Pradesh
- Recruiting
Government General Hospital
Guntur, Andhra Pradesh
- Recruiting
Medical Superintendent District Hospital
Hindupur PPP, Andhra Pradesh
- Recruiting
Fortis Suchirayu Hospital
Hubli, Karnataka
- Recruiting
Citizens Specialty Hospital
Hyderabad, Telangana
- Recruiting
ESI Multi-Specialty Hospital
Hyderabad, Telangana
- Recruiting
Vintage Plaza Nephroplus, Road no. 10, Banjara Hills
Hyderabad, Telangana
- Recruiting
Vishesh Hospital Pvt. Ltd, Geeta Bhawan Chouraha
Indore, Madhya Pradesh
- Recruiting
Government Hospital
Kākināda, Andhra Pradesh
- Recruiting
Government Area Hospital, Kanigiri, Andhra Pradesh
Kanigiri, Andhra Pradesh
- Recruiting
Madhuraj Hospital
Kanpur, Uttar Pradesh
- Recruiting
Government Hospital
Khammam, Telangana
- Recruiting
Aysha Hospital
Kilpauk, Chennai
- Recruiting
Retteri Sri Kumaran Health Centre
Kolathūr, Chennai
- Recruiting
Health Point Hospital, Prannth Pandit Street
Kolkata, West Bengal
- Recruiting
Main Hospital, SCCL
Kothagudem, Khammam
- Recruiting
Government General Hospital
Kurnool, Andhra Pradesh
- Recruiting
Ajanta Hospital
Lucknow, Uttar Pradesh
- Recruiting
Satguru Partap Singh Apollo Hospitals
Ludhiana, Punjab
- Recruiting
Government Hospital, Machilipatnam PPP, Andhra Pradesh
Machilipatnam, Andhra Pradesh
- Recruiting
Government Area Hospital
Mārkāpur, Andhra Pradesh
- Recruiting
Hitwardhak Mandal Hospital
Mumbai, Maharashtra
Kamal D Shah
Abhinav Bassi
- Recruiting
Suraksha Multispecialty Hospital
Nalgonda, Telangana
- Recruiting
Government Hospital
Nandyāl, Andhra Pradesh
- Recruiting
Area Hospital
Narsīpatnam, Andhra Pradesh
- Recruiting
Neyveli Lignite Corporation Hospital
Neyveli, Tamil Nadu
- Recruiting
Sudha Hospital, Vadalur
Neyveli, Tamil Nadu
- Recruiting
Surbhi Hospital Pvt. Ltd, Sector 35
Noida, Uttar Pradish
- Recruiting
Greater Kailash Hospital
Old Palasia, Indore
- Recruiting
Government Area Hospital
Palakonda, Srikakulam District, Andhra Pradesh
- Recruiting
CHC Government Hospital
Palāsa, Andhra Pradesh
- Recruiting
Government Area Hospital
Pārvathipuram, Andhra Pradesh
- Recruiting
Ford Hospital, Khemnichak, Patna
Patna, Bihar
- Recruiting
Janak Dulari Hospital, Hanuman Nagar
Patna, Bihar
- Recruiting
Government Hospital
Proddatūr, Andhra Pradesh
- Recruiting
Lokmanya Hospital
Pune, Maharashtra
- Recruiting
Government Hospital
Rajahmundry, Andhra Pradesh
- Recruiting
Bhagwan Mahavir Medical Superspeciality Hospital
Ranchi, Jharkhand
- Recruiting
Guru Nanak Hospital and Research Centre
Ranchi, Jharkhand
- Recruiting
Nephroplus Standalone Dialysis Center, Easy Marredpally
Secunderabad, Telangana
- Recruiting
CHC Hospital, Sompeta, Andhra Pradesh
Sompeta, Andhra Pradesh
- Recruiting
Rajiv Gandhi Institute of Medical Sciences, Srikakulam PPP, Andhra
Srikakulam, Telangana
- Recruiting
Greater Kailash Hospital
Tadepalligudem, Andhra Pradesh
- Recruiting
Minimal Access Surgery Clinic Pvt Ltd
Tamlūk, West Bengal
- Recruiting
Chirayu Hospital
Thane, Maharashtra
- Recruiting
Manasa Kidney Foundation
Tirupati, Andhra Pradesh
- Recruiting
Baroma Sirona Hospital
Uttar Mechgram, West Bengal
- Recruiting
Government General Hospital, Vijayavada PPP, Andhra Pradesh
Vijayawada, Andhra Pradesh
- Recruiting
King George Government Hospital
Visakhapatnam, Andhra Pradesh
Malaysia39 sites, 38 recruiting
- Recruiting
Hospital Ampang
Ampang
- Recruiting
Hospital Sultanah Nora Ismail
Batu Pahat
- Recruiting
Hospital Beaufort
Beaufort
- Recruiting
Hospital Pulau Pinang
George Town
- Recruiting
Pusat Dialisis NKF- Yayasan Dialisis Pendidikan Akhlak Perak
Ipoh
- Recruiting
Hospital Sultan Ismail
Johor Bahru
- Recruiting
Hospital Sultanah Aminah
Johor Bahru
- Recruiting
Hospital Kajang
Kajang
- Recruiting
Hospital Serdang
Kajang
- Completed
Hospital Tuanku Fauziah
Kangar
- Recruiting
Pusat Rawatan Dialisis Tuanku Syed Putra - NKF
Kangar
- Recruiting
Hospital Tengku Ampuan Rahimah
Klang
- Recruiting
Pusat Daillisis NKF - Kelab Apex
Klang
- Recruiting
Hospital Raja Perempuan Zainab II
Kota Bharu
- Recruiting
Hospital Likas
Kota Kinabalu
- Recruiting
Hospital Queen Elizabeth II
Kota Kinabalu
- Recruiting
Hospital Kuala Kangsar
Kuala Kangsar
- Recruiting
Hospital Kuala Lipis
Kuala Lipis
- Recruiting
Hospital Kuala Lumpur
Kuala Lumpur
- Recruiting
Pusat Dialisis NKF-Fungates Superflow
Kuala Lumpur
- Recruiting
Pusat Dialisis NKF-Nanyang
Kuala Lumpur
- Recruiting
Universiti Kebangsaan Malaysia Medical Centre
Kuala Lumpur
- Recruiting
University of Malaya Medical Centre
Kuala Lumpur
- Recruiting
Hospital Tengku Ampuan Afzan
Kuantan
- Recruiting
Hospital Kudat
Kudat
- Recruiting
Hospital Kulim
Kulim
- Recruiting
Hospital Labuan
Labuan
- Recruiting
Hospital Sultanah Bahiyah
Langgar
- Recruiting
Haemodialysis Unit Klinik Kesihatan Lenggong
Lenggong
- Recruiting
Pusat Hemodialisis Komuniti Cheng
Malacca
- Recruiting
Hospital Pakar Sultanah Fatimah
Muar town
- Recruiting
Hospital Seberang Jaya
Permatang Pauh
- Recruiting
Pusat Dialisis NKF - Chempaka
Petaling Jaya
- Recruiting
Hospital Shah Alam
Shah Alam
- Recruiting
Universiti Teknologi Mara
Shah Alam
- Recruiting
Hospital Sultan Abdul Halim
Sungai Petani
- Recruiting
Hospital Sungai Siput
Sungai Siput
- Recruiting
Hospital Tambunan
Tambunan
- Recruiting
Hospital Sultan Haji Ahmad Shah
Temerluh
Australia31 sites, 31 recruiting
- Recruiting
Royal Adelaide Hospital
Adelaide
- Recruiting
Auburn Hospital
Auburn, 2144
- Recruiting
Flinders Medical Centre
Bedford Park
- Recruiting
Moorabbin Hospital
Bentleigh East, 3165
- Recruiting
Sunshine Coast University Private Hospital
Birtinya
- Recruiting
Princess Alexandra Hospital
Brisbane, 4102
- Recruiting
Redlands Hospital
Brisbane, 4163
- Recruiting
Bundaberg Hospital
Bundaberg
- Recruiting
Caloundra Hospital
Caloundra, 4551
- Recruiting
Royal Prince Alfred Hospital
Camperdown
- Recruiting
The Canberra Hospital
Canberra
- Recruiting
Peninsula Health
Frankston, 3199
- Recruiting
Gympie Hospital
Gympie, 4570
- Recruiting
Ipswich Hospital
Ipswich, 4305
- Recruiting
Mackay Base Hospital
Mackay
- Recruiting
Logan Hospital
Meadowbrook, 4131
- Recruiting
Monash Health Community Dandenong
Melbourne, 3175
- Recruiting
Casey Hospital
Melbourne, 3806
- Recruiting
Cranbourne Integrated Care Centre
Melbourne, 3977
- Recruiting
Nambour General Hospital
Nambour, 4560
- Recruiting
Hampstead Dialysis Centre
Northfield
- Recruiting
Hervey Bay Hospital
Pialba
- Recruiting
Royal North Shore Hospital
St Leonards
- Recruiting
Sunshine Coast University Hospital
Sunshine Coast, 4575
- Recruiting
Sydney Adventist Hospital
Sydney, 2076
- Recruiting
Concord Repatriation and General Hospital
Sydney, 2139
- Recruiting
Blacktown Regional Dialysis Centre
Sydney, 2148
- Recruiting
Mt Druitt Community Dialysis Centre
Sydney, 2770
- Recruiting
Nepean Hospital
Sydney
- Recruiting
Westmead Hospital
Sydney
- Recruiting
The Queen Elizabeth Hospital
Woodville South
Canada20 sites, 20 recruiting
- Recruiting
Brantford General Hospital
Brantford, Ontario
- Recruiting
Chatam-Kent Health Alliance
Chatham, Ontario
- Recruiting
St Joseph's Healthcare
Hamilton, Ontario
- Recruiting
Stoney Creek
Hamilton
- Recruiting
Hanover District Hospital
Hanover, Ontario
- Recruiting
Belleville
Kingston
- Recruiting
Brockville
Kingston
- Recruiting
Kingston General
Kingston
- Recruiting
Napanee
Kingston
- Recruiting
Perth and Smith Falls
Kingston
- Recruiting
Picton
Kingston
- Recruiting
Adam Linton Dialysis Unit - Victoria Hospital
London, Ontario
- Recruiting
London Health Sciences Centre
London, Ontario
- Recruiting
Westmount Kidney Care Centre
London, Ontario
- Recruiting
Grey Bruce Health Services
Owen Sound, Ontario
- Recruiting
Bluewater Hospital
Sarnia, Ontario
- Recruiting
Huron Perth Hospital Partnership
Stratford, Ontario
- Recruiting
Tillsonburg District Memorial Hospital
Tillsonburg, Ontario
- Recruiting
St. Michael's Hospital
Toronto
- Recruiting
Woodstock General Hospital
Woodstock, Ontario
Germany16 sites, 16 recruiting
- Recruiting
Nephrologisches Zentrum Albstadt
Albstadt
- Recruiting
Praxis für Nierenkrankheiten Berlin Hellersdorf
Berlin
- Recruiting
Dialyse am Kortumpark Bochum
Bochum
- Recruiting
Dialysezentrum Darmstadt
Darmstadt
- Recruiting
Dialysezentrum Elsenfeld
Elsenfeld
- Recruiting
Nephrologisches Zentrum Hechingen
Hechingen
- Recruiting
Arbeitsgemeinschaft Heimdialyse Saar e.V.
Homburg
- Recruiting
Dialysezentrum Langen
Langen
- Recruiting
KfH Nierenzentrum Lichtenfels
Lichtenfels
- Recruiting
Universitätsmedizin Mainz, Dialysestation 605-5E
Mainz
- Recruiting
KfH Nierenzentrum München Schwabing
Munich
- Recruiting
UBAG Öhringen
Öhringen
- Recruiting
Dialysezentrum Schweinfurt
Schweinfurt
- Recruiting
Dialysezentrum Siegburg
Siegburg
- Recruiting
Nephrologie - Dialyse - Christliches Klinikum Unna
Unna
- Recruiting
Nephrologisches Zentrum Villingen-Schwenningen -Tuttlingen
Villingen-Schwenningen, 78052
About this study
This global study will assess the effect of randomising dialysis sites to one of two default dialysate sodium concentrations in current practice, 140mmol/l and 137mmol/l, on major cardiovascular events and death in patients receiving maintenance haemodialysis.
Read the detailed description
RESOLVE is a pragmatic, cluster-randomised, open-label study designed to evaluate in real-world conditions the comparative effectiveness of two default dialysate sodium concentrations.
Dialysis sites will be randomised in a 1:1 ratio to a default dialysate sodium concentration of 137mmol/l or 140mmol/l. 'Default' is defined as the use of the allocated dialysate sodium for ≥ 90% of delivered dialysis sessions in the unit. All other care will be according to standard local practices as determined by the site.
Outcomes will be assessed on individual patients dialysing at those sites. Sites will be asked to consent to participation while waiver or opt-out consent will be sought for individual patients.
It is anticipated that site accrual will occur over 5-7 years with average study duration expected to be approximately 2-5 years. The actual length of the study will be end-point determined.
- Conditions
- End-Stage Kidney Disease
- Being tested
- Default dialysate sodium concentration of 137mmol/l, Default dialysate sodium concentration of 140mmol/l
- Keywords
- End-Stage Kidney Disease, Hemodialysis, Dialysate, Sodium, Cluster-randomisation, Dialysis, RESOLVE
- Medical subject headings
- Kidney Failure, Chronic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Default dialysate sodium concentration of 137mmol/lOther
Default defined here as use of allocated dialysate sodium concentration for at least 90% of delivered dialysis sessions.
Default dialysate sodium concentration of 140mmol/lOther
Default defined here as use of allocated dialysate sodium concentration for at least 90% of delivered dialysis sessions.
| Study group | Role | What they receive |
|---|---|---|
| 137mmol/l | Active comparator | Participating dialysis sites will be randomised to a default dialysate sodium concentration of 137mmol/l Receives: Other: Default dialysate sodium concentration of 137mmol/l |
| 140mmol/l | Active comparator | Participating dialysis sites will be randomised to a default dialysate sodium concentration of 140mmol/l Receives: Other: Default dialysate sodium concentration of 140mmol/l |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time to first occurrence of an event in the primary composite outcome
Primary outcome is a composite of major cardiovascular events (hospitalised acute myocardial infarction, hospitalised stroke) and all-cause death. Study completion is endpoint driven, but is expected to be when the average follow up is around 5 years.
Measured: Through to study completion (estimated to occur after an average of 5 years follow up)
Secondary outcomes (2)
Time to first occurrence of an event in the secondary composite outcome
Secondary outcome comprises major cardiovascular events (hospitalized acute myocardial infarction, hospitalized stroke), all-cause death and hospitalized heart failure. Study completion is endpoint driven, but is expected to be when the average follow up is around 5 years.
Measured: Through to study completion (estimated to occur after an average of 5 years follow up)
Time to first occurrence of each of the individual components of the composite outcomes.
These components are hospitalised myocardial infarctions, hospitalised strokes, hospitalised heart failures and all-cause deaths. Study completion is endpoint driven, but is expected to be when the average follow up is around 5 years.
Measured: Through to study completion (estimated to occur after an average of 5 years follow up)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jul 2016 (estimated)
- Study startJun 2016
- Primary completionDec 2026 (estimated)
- Study completionDec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for End-Stage Kidney DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 50,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Sydney
- Sponsor type
- University, hospital or other
- Collaborators
- Australasian Kidney Trials Network, Australia & New Zealand Dialysis & Transplant Registry, The George Institute, The George Institute for Global Health, China, Peking University People's Hospital, Institute for Clinical Evaluative Sciences, St. Michaels Hospital, Wuerzburg University Hospital, Malaysian Society of Nephrology, Malaysian Renal Registry, University College, London
- Responsible party
- Sponsor
- Investigators
- Meg Jardine, Study director, The University of Sydney, NHMRC Clinical Trials CentreCarmel Hawley, Study chair, The University of QueenslandVivekanand Jha, Study chair, The George Institute IndiaZuo Li, Study chair, Peking University People's HospitalSunita Bavanandan, Study chair, Kuala Lumpur General HospitalDavid Wheeler, Study chair, University College, LondonPatrick Rossignol, Study chair, INSERM Clinical Investigation CentreMike Walsh, Study chair, McMaster University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02823821
- Sponsor's protocol ID
- GI-AU-RM-2016-01
- Acronym
- RESOLVE
- Status last verified
- Apr 2025
- First submitted
- 16 Jun 2016
- Last updated
- 4 Apr 2025
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- No
Publications
Pinter J, Canaud B, Mayne KJ, Stuard S, Moissl U, Kooman J, Jager KJ, Chesnaye NC, Smyth B, Genser B. Associations of Abnormal Fluid Status, Plasma Sodium Disorders, and Low Dialysate Sodium with Mortality in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2024 Nov 1;19(11):1444-1452. doi: 10.2215/CJN.0000000000000552. Epub 2024 Sep 10.
PubMed 39514693Marshall MR, Wang MY, Vandal AC, Dunlop JL. Low dialysate sodium levels for chronic haemodialysis. Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD011204. doi: 10.1002/14651858.CD011204.pub3.
PubMed 39498822See EJ, Polkinghorne KR. Volume management in haemodialysis patients. Curr Opin Nephrol Hypertens. 2020 Nov;29(6):663-670. doi: 10.1097/MNH.0000000000000642.
PubMed 32889978
Study at a glance
From the registry record, last updated by the sponsor on 4 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
- ClinicalTrials.gov ID
- NCT02823821
- Acronym / sponsor ID
- RESOLVE / GI-AU-RM-2016-01
- Conditions
- End-Stage Kidney Disease
- Keywords
- End-Stage Kidney Disease, Hemodialysis, Dialysate, Sodium, Cluster-randomisation, Dialysis, RESOLVE
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 50,000 participants (estimated)
- Lead sponsor
- University of SydneyUniversity, hospital or other
- Collaborators
- Australasian Kidney Trials Network, Australia & New Zealand Dialysis & Transplant Registry, The George Institute, The George Institute for Global Health, China, Peking University People's Hospital, Institute for Clinical Evaluative Sciences, St. Michaels Hospital, Wuerzburg University Hospital, Malaysian Society of Nephrology, Malaysian Renal Registry, University College, London
- Study start
- Jun 2016 (actual)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Dec 2026 (estimated)
- First posted
- 6 Jul 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This global study will assess the effect of randomising dialysis sites to one of two default dialysate sodium concentrations in current practice, 140mmol/l and 137mmol/l, on major cardiovascular events and death in patients receiving maintenance haemodialysis.
Detailed description
RESOLVE is a pragmatic, cluster-randomised, open-label study designed to evaluate in real-world conditions the comparative effectiveness of two default dialysate sodium concentrations.
Dialysis sites will be randomised in a 1:1 ratio to a default dialysate sodium concentration of 137mmol/l or 140mmol/l. 'Default' is defined as the use of the allocated dialysate sodium for ≥ 90% of delivered dialysis sessions in the unit. All other care will be according to standard local practices as determined by the site.
Outcomes will be assessed on individual patients dialysing at those sites. Sites will be asked to consent to participation while waiver or opt-out consent will be sought for individual patients.
It is anticipated that site accrual will occur over 5-7 years with average study duration expected to be approximately 2-5 years. The actual length of the study will be end-point determined.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 137mmol/l | Active comparator | Other: Default dialysate sodium concentration of 137mmol/lParticipating dialysis sites will be randomised to a default dialysate sodium concentration of 137mmol/l |
| 140mmol/l | Active comparator | Other: Default dialysate sodium concentration of 140mmol/lParticipating dialysis sites will be randomised to a default dialysate sodium concentration of 140mmol/l |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Default dialysate sodium concentration of 137mmol/lDefault defined here as use of allocated dialysate sodium concentration for at least 90% of delivered dialysis sessions. | Other | 137mmol/l |
| Default dialysate sodium concentration of 140mmol/lDefault defined here as use of allocated dialysate sodium concentration for at least 90% of delivered dialysis sessions. | Other | 140mmol/l |
Primary outcome
Time to first occurrence of an event in the primary composite outcome
Time frame: Through to study completion (estimated to occur after an average of 5 years follow up)
Primary outcome is a composite of major cardiovascular events (hospitalised acute myocardial infarction, hospitalised stroke) and all-cause death. Study completion is endpoint driven, but is expected to be when the average follow up is around 5 years.
2 secondary outcomes
Time to first occurrence of an event in the secondary composite outcome
Time frame: Through to study completion (estimated to occur after an average of 5 years follow up)
Time to first occurrence of each of the individual components of the composite outcomes.
Time frame: Through to study completion (estimated to occur after an average of 5 years follow up)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Apr 2025.
- Derived from this study: PubMed 39514693Pinter J, Canaud B, Mayne KJ, Stuard S, Moissl U, Kooman J, Jager KJ, Chesnaye NC, Smyth B, Genser B. Associations of Abnormal Fluid Status, Plasma Sodium Disorders, and Low Dialysate Sodium with Mortality in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2024 Nov 1;19(11):1444-1452. doi: 10.2215/CJN.0000000000000552. Epub 2024 Sep 10.
- Derived from this study: PubMed 39498822Marshall MR, Wang MY, Vandal AC, Dunlop JL. Low dialysate sodium levels for chronic haemodialysis. Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD011204. doi: 10.1002/14651858.CD011204.pub3.
- Derived from this study: PubMed 32889978See EJ, Polkinghorne KR. Volume management in haemodialysis patients. Curr Opin Nephrol Hypertens. 2020 Nov;29(6):663-670. doi: 10.1097/MNH.0000000000000642.
- Individual participant dataSharing planned: No
Related trials for End-Stage Kidney Disease
Active, not recruitingPhase 2
Safety and Efficacy of Empagliflozin in Hemodialysis
End Stage Renal Disease
Not yet recruiting
Hypothermic Kidney Machine Perfusion With Omnisol
End Stage Renal Disease (ESRD), Kidney Transplant
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
RecruitingObservational study
Physical Impairments in Children With Chronic Renal Failure
Chronic Kidney Failure, Chronic Kidney Diseases
RecruitingPhase 1
A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on Dialysis
End Stage Renal Disease on Dialysis, Adult
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Grace Balicki contact
Erika Dempsey contact
Meg Jardine study director
The University of Sydney, NHMRC Clinical Trials Centre
Carmel Hawley study chair
The University of Queensland
Vivekanand Jha study chair
The George Institute India
264 sites in 6 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing Default dialysate sodium concentration of 137mmol/l and Default dialysate sodium concentration of 140mmol/l in people with End-Stage Kidney Disease, run by University of Sydney at 264 sites in 6 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 4 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 264 sites in United Kingdom, India, Malaysia, Australia, Canada and 1 more country. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Grace Balicki (grace.balicki@sydney.edu.au), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time to first occurrence of an event in the primary composite outcome (time frame: Through to study completion (estimated to occur after an average of 5 years follow up)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02823821, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2025.